Actively Recruiting

Age: 18Years - 65Years
All Genders
NCT06406972

Brief Admission by Self-referral for Individuals With Self-harm: Effects on Compulsory Care

Led by Region Skane · Updated on 2025-08-14

7000

Participants Needed

4

Research Sites

798 weeks

Total Duration

On this page

Sponsors

R

Region Skane

Lead Sponsor

L

Lund University

Collaborating Sponsor

AI-Summary

What this Trial Is About

Brief Admission by self-referral (BA) is a standardized treatment model, providing patient-controlled and person-centered care. It was developed to reduce self-harm and compulsory care by promoting autonomy. Randomized clinical trials have not yielded significant between group differences with respect to inpatient care, including compulsory care. The major difficulty in evaluating BA is preventing the control group from cross-contamination, as in the implementation process of BA, all physicians, all inpatient and outpatient staff as well as managers need to be informed and undergo basic education regarding the intervention. As BA addresses a prevalent and frustrating issue in psychiatric health care, there is considerable risk that the approach leaks to the control group, reducing the possibility to detect between-group differences. In the current study this will be addressed through a register-based approach, comparing similar clinics, implementing BA at different timepoints over time. Individuals with traits of borderline personality disorder will be included and comparisons will be made with respect to compulsory care, voluntary inpatient care and mortality.

CONDITIONS

Official Title

Brief Admission by Self-referral for Individuals With Self-harm: Effects on Compulsory Care

Who Can Participate

Age: 18Years - 65Years
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Living in the uptake area of Lund, Linköping, Helsingborg or Norrköping
  • Age 18-65 years at the time of inclusion
  • Admitted to hospital with ICD-10 diagnosis borderline personality disorder (BPD) F60.3, or admitted at least twice with intentional self-harm (X60-83) combined with one or more of the following diagnoses: ADHD (F90.0-F90.X), bipolar disorder type 2 (F31.8W, F318A-F, F31.0, F31.8-9, F31.8W), autism, atypical autism, Asperger's syndrome (F84.0, F84.1, F84.5), or mild intellectual disability (F70.0-F70.9)
Not Eligible

You will not qualify if you...

  • Not fulfilling the inclusion criteria

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 4 locations

1

Division of Psychiatry, Region Skåne

Lund, Skåne County, Sweden, 22185

Actively Recruiting

2

Region Östergötland

Linköping, Sweden, 581 91

Actively Recruiting

3

Statistiska centralbyrån

Solna, Sweden, 171 54

Actively Recruiting

4

Socialstyrelsen

Stockholm, Sweden, SE-106 30

Actively Recruiting

Loading map...

Research Team

S

Sofie Sofie, PhD

CONTACT

J

Josefin Vikström Eckevall, PhD

CONTACT

How is the study designed?

Study Type

OBSERVATIONAL

Masking

N/A

Allocation

N/A

Model

N/A

Primary Purpose

N/A

Number of Arms

12

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here